Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2000-6-23
pubmed:abstractText
3,4-Dihydroxyphenylacetaldehyde (DOPAL) has been reported to be a toxic metabolite formed by the oxidative-deamination of dopamine (DA) catalyzed by monoamine oxidase. This aldehyde is either oxidized to 3,4-dihydroxyphenylacetic acid (DOPAC) by aldehyde dehydrogenase, an NAD-dependent enzyme or reduced to 3, 4-dihydroxyphenylethanol (DOPET) by aldehyde or aldose reductase. In the present study we examined whether levels of DOPAL are elevated by inhibition of the mitochondrial respiratory chain. Using inhibitors of mitochondrial complexes I, II, III and IV we found that inhibition of complex I and III increased levels of DOPAL and DOPET. Nerve growth factor-induced differentiation of PC12 cells markedly potentiated DOPAL and DOPET accumulation in response to metabolic stress. DOPAL was toxic to differentiated PC12 as well as to SK-N-SH cell lines. Because complex I dysfunction has been implicated in the pathogenesis of Parkinson's disease, the accumulation of DOPAL may explain the vulnerability of the dopaminergic system to complex I inhibition. The rapid appearance of DOPAL and DOPET after inhibition of complex I may be a useful early index of oxidative stress in DA-forming neurons.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0360-4012
pubmed:author
pubmed:copyrightInfo
Copyright 2000 Wiley-Liss, Inc.
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
552-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:10797558-3,4-Dihydroxyphenylacetic Acid, pubmed-meshheading:10797558-Animals, pubmed-meshheading:10797558-Cell Differentiation, pubmed-meshheading:10797558-Cell Line, pubmed-meshheading:10797558-Cell Survival, pubmed-meshheading:10797558-Dopamine, pubmed-meshheading:10797558-Dose-Response Relationship, Drug, pubmed-meshheading:10797558-Electron Transport, pubmed-meshheading:10797558-Glucose, pubmed-meshheading:10797558-Homovanillic Acid, pubmed-meshheading:10797558-Humans, pubmed-meshheading:10797558-L-Lactate Dehydrogenase, pubmed-meshheading:10797558-Mitochondria, pubmed-meshheading:10797558-Nerve Growth Factor, pubmed-meshheading:10797558-Neurons, pubmed-meshheading:10797558-Neurotoxins, pubmed-meshheading:10797558-Oxidation-Reduction, pubmed-meshheading:10797558-PC12 Cells, pubmed-meshheading:10797558-Phenylethyl Alcohol, pubmed-meshheading:10797558-Rats, pubmed-meshheading:10797558-Rotenone, pubmed-meshheading:10797558-Stress, Physiological, pubmed-meshheading:10797558-Uncoupling Agents
pubmed:year
2000
pubmed:articleTitle
Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4-dihydroxyphenylacetaldehyde.
pubmed:affiliation
CNS, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. lamensdo@helix.nih.gov
pubmed:publicationType
Journal Article